Relaxin    (DrugBank: -)

1 disease
告示番号疾患名(ページ内リンク)臨床試験数
51全身性強皮症2

51. 全身性強皮症 [臨床試験数:466,薬物数:536(DrugBank:142),標的遺伝子数:110,標的パスウェイ数:210
Searched query = "Scleroderma", "Systemic sclerosis", "SSc", "dcSSc", "lcSSc"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 466 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00704665
(ClinicalTrials.gov)
December 199823/6/2008Recombinant Human Relaxin in the Treatment of Diffuse SclerodermaA Randomized, Double-Blind, Placebo-Controlled Trial of Recombinant Human Relaxin in the Treatment of Systemic Sclerosis With Diffuse SclerodermaSystemic SclerosisDrug: RelaxinUniversity of Medicine and Dentistry of New JerseyUniversity of California, Los Angeles;Boston University;University of Chicago;University of Connecticut Health Center;Johns Hopkins University;University of Pittsburgh;Medical University of South Carolina;Stanford University;Georgetown University;University of California, San Diego;Wayne State University;University of Colorado, Denver;Medical College of WisconsinCompleted18 Years70 YearsBoth231Phase 3NULL
2NCT00004380
(ClinicalTrials.gov)
December 199118/10/1999Phase II Study of Recombinant Relaxin for Progressive Systemic SclerosisSystemic SclerosisDrug: relaxinNational Center for Research Resources (NCRR)National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS);Stanford UniversityCompletedN/AN/ABoth1Phase 2NULL